Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of RC017 Ophthalmic Ointment Following Single and Multiple Doses in Healthy Adult Participants [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of RC017 Ophthalmic Ointment in healthy adults, including single and multiple dose co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• RC017 Ophthalmic Ointment (RC017)

Snippet

Sponsor: Nanjing Reju Therapeutics Co., Ltd | Conditions: Dry Eye | Phase 1 | Status: NOT_YET_RECRUITING